Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Retained Earnings
Cumulative profits kept in the business rather than paid out as dividends.
Retained Earnings history
Currency unavailable · from the balance sheet
No Retained Earnings data reported for this period type.
Retained Earnings vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | -€164.27M EUR | — | — | 99.2% |
| Jun 2026 | -$304.04M USD | +21.4% | — | 34.3% | |
ORKAOruka Therapeutics, Inc. | Sep 2026 | -$312.15M USD | -95.6% | — | 25.4% |
| Mar 2026 | -$641.16M USD | -19.4% | — | 337.9% | |
| Mar 2026 | -$825.44M USD | -3.4% | — | 250.4% | |
| Mar 2026 | -$987.61M USD | -7.6% | — | 497.0% | |
ALMSAlumis Inc. Common Stock | Jun 2026 | -$1.14B USD | -62.9% | — | 202.8% |
| Sep 2026 | -$1.33B USD | -24.8% | — | 120.8% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | -19.4% | — | 161.8% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.